Barinthus Biotherapeutics (BRNS) Depreciation and Depletion (2022 - 2026)
Barinthus Biotherapeutics (BRNS) reported Depreciation and Depletion of $200000.0 for Q1 2026, down 83.33% on a YoY basis from $1.2 million in Q1 2025, and down 33.33% quarter-over-quarter from $300000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Depreciation and Depletion (2022 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Depreciation and Depletion for 5 years, with the latest figure at $200000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 83.33% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 43.75% YoY), and the FY2025 full-year result was $2.9 million, up 11.54% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $200000.0, down from $300000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $1.2 million in Q1 2025, with the low at $100000.0 in Q3 2025.
- Historically, Depreciation and Depletion has averaged $529411.8 across 5 years, with a median of $500000.0 in 2023.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion soared 150.0% — and 2025, when it sank 85.71%.
- Barinthus Biotherapeutics' Depreciation and Depletion stood at $300000.0 in 2022, then soared by 133.33% to $700000.0 in 2023, then decreased by 14.29% to $600000.0 in 2024, then slumped by 50.0% to $300000.0 in 2025, then plunged by 33.33% to $200000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $200000.0 (Q1 2026), $300000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |